Cargando…
Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer
Tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine proteinase inhibitor that inhibits plasmin-dependent activation of several metalloproteinases. Downregulation of TFPI-2 could thus enhance the invasive potential of neoplastic cells in several cancers, including lung cancer. In this...
Autores principales: | Rollin, J, Iochmann, S, Bléchet, C, Hubé, F, Régina, S, Guyétant, S, Lemarié, E, Reverdiau, P, Gruel, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361876/ https://www.ncbi.nlm.nih.gov/pubmed/15685245 http://dx.doi.org/10.1038/sj.bjc.6602298 |
Ejemplares similares
-
Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer()
por: Lavergne, Marion, et al.
Publicado: (2013) -
The Intracellular Localization of ID2 Expression Has a Predictive Value in Non Small Cell Lung Cancer
por: Rollin, Jérôme, et al.
Publicado: (2009) -
High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis
por: Nathalie, Heuzé-Vourc’h, et al.
Publicado: (2009) -
The relationship between aberrant methylation and survival in non-small-cell lung cancers
por: Toyooka, S, et al.
Publicado: (2004) -
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum
por: Belinsky, S A, et al.
Publicado: (2007)